VOR
Vor Biopharma IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$776.48M
P/E Ratio
—
EPS
$-70.40
Beta
1.75
52W High
$65.80
52W Low
$3.30
50-Day MA
$14.98
200-Day MA
$20.32
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Vor Biopharma Inc
Vor Biopharma, Inc., an early stage cell therapy company, develops hematopoietic stem cell (eHSC) therapies designed for cancer patients. The company is headquartered in Cambridge, Massachusetts.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-341.72M |
| Operating Margin | 0.00% |
| Return on Equity | -125.40% |
| Return on Assets | -69.80% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-4.24 |
| Price-to-Book | 0.66 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -3.09 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $54.19M |
| Float | $43.71M |
| % Insiders | 4.29% |
| % Institutions | 69.39% |
Historical Volatility
HV 10-Day
72.01%
HV 20-Day
67.37%
HV 30-Day
70.64%
HV 60-Day
82.76%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($37.88 target)
1
Strong Buy7
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026